🔎 Trials Near Me

Почетна › Вилмов тумор › Тенеси

Kliničke studije za Вилмов тумор u državi Тенеси

6 studija za Вилмов тумор traži učesnike na lokacijama u državi Тенеси.

Gradovi u državi Тенеси

Zvanični tekst studije (na engleskom)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • Saint Jude Children's Research Hospital, Memphis
Тражи се учесникФаза 2
Узраст од 12 до 39 · Оба пола · Ажурирано 12. 11. 2026. · NCT04616560

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • East Tennessee Childrens Hospital, Knoxville
  • Saint Jude Children's Research Hospital, Memphis
  • The Children's Hospital at TriStar Centennial, Nashville
  • и још 1
Тражи се учесникФаза 2
До 30 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04322318

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Saint Jude Children's Research Hospital, Memphis
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • St. Jude Children's Research Hospital, Memphis
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 19. 5. 2026. · NCT04901702

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

  • St. Jude Children's Research Hospital, Memphis
Тражи се учесникФаза 1
До 21 година · Оба пола · Ажурирано 19. 5. 2026. · NCT04897321

Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation

  • St.Jude Children's Research Hospital, Memphis
Тражи се учесникФаза 2
Сви узрасти · Оба пола · Ажурирано 23. 4. 2026. · NCT04968990

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.